企業プロフィール
QAthersys, Inc. 株価・ニュース・カタリスト
- ティッカー:
- ATHX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for ATHX.
企業概要
事業概要
Athersys was a regenerative medicine company focused on cell therapy and acute inflammatory conditions before becoming a historical biotech name. Its story revolved around stem-cell science and the challenge of moving it into a practical treatment.
所在地とセクター分類
Athersys was headquartered in the United States and listed on NASDAQ. It sat in regenerative medicine and biotechnology.
ビジネスモデルの特徴
The company depended on clinical proof, manufacturing feasibility, and a constant need for financing. Investors historically followed readouts, strategic shifts, and whether the platform could survive long enough to scale.
バイオ業界での位置付け
Athersys occupies the historical regenerative-medicine bucket. Like many cell-therapy developers, it was highly sensitive to capital and clinical execution.
今後のカタリスト
- Athersys is largely a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update. The market is mainly focused on what remains after the restructuring.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。